Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
NCT02149303
·
clinicaltrials.gov ↗
COMPLETED
Status
191
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Hemorrhage
Interventions
DRUG:
Dabigatran 75 mg
DRUG:
Dabigatran 150 mg
Sponsor
Boehringer Ingelheim